New research has found that Cannnabidiol is active against Gram-positive bacteria, including those responsible for many serious infections (such as Staphyloccocus aureus and Streptococcus pneumoniae), with potency similar to that of established antibiotics such as vancomycin or daptomycin.
The research is presented at ASM Microbe, the annual meeting of the American Society for Microbiology.
Cannabidiol, the main non-psychoactive chemical compound extracted from cannabis and hemp plants, has been approved by FDA for the treatment of a form of epilepsy, and is being investigated for a number of other medical conditions, including, anxiety, pain and inflammation. While there is limited data to suggest Cannabidiol can kill bacteria, the drug has not been thoroughly investigated for its potential as an antibiotic.
Work led by Dr Mark Blaskovich at The University of Queensland’s Institute for Molecular Bioscience’s Centre for Superbug Solutions, in collaboration with Botanix Pharmaceuticals Ltd, an early stage drug discovery company investigating topical uses of synthetic cannabidiol for a range of skin conditions, found that Cannabidiol was remarkably effective at killing a wide range of Gram-positive bacteria, including bacteria that have become resistant to other antibiotics, and did not lose effectiveness after extended treatment.
“Given cannabidiol’s documented anti-inflammatory effects, existing safety data in humans, and potential for varied delivery routes, it is a promising new antibiotic worth further investigation,” said Dr. Blaskovich. “The combination of inherent antimicrobial activity and potential to reduce damage caused by the inflammatory response to infections is particularly attractive.”
Importantly, the drug retained its activity against bacteria that have become highly resistant to other common antibiotics. Under extended exposure conditions that lead to resistance against vancomycin or daptomycin, Cannabidiol did not lose effectiveness. Cannabidiol was also effective at disrupting biofilms, a physical form of bacteria growth that leads to difficult-to-treat infections.
The project was co-funded by Botanix and Innovation Connections, an Australian government grant scheme to commercialize new products, processes and services. The paper will be presented on Sunday June 23rd from 11am-1 pm at the annual conference of the American Society for Microbiology, ASM Microbe 2019, at the Moscone Convention Center in San Francisco.
Learn more: Cannabidiol is a Powerful New Antibiotic
The Latest on: Cannnabidiol
via Google News
The Latest on: Cannnabidiol
- Cannabidiol Shows Sustained Benefit in Rare, Severe Forms of Epilepsyon December 8, 2021 at 2:46 pm
Epidiolex, a pharmaceutical formulation of cannabidiol (CBD), continued to show benefits for people with Lennox-Gastaut syndrome and Dravet syndrome, real-world data showed. Seizure frequency was ...
- Is ‘Vena CBD’ Legit?on December 8, 2021 at 7:00 am
When it comes to ‘Vena CBD,’ we enjoyed testing this CBD and were pleasantly surprised by the amount it was packing. If you are looking for a high-dose CBD isolate oil, this is a good choice for ...
- Lexaria Bioscience Shares Rise 25% Premarket on Positive Trial Resultson December 8, 2021 at 4:59 am
By Chris Wack Lexaria Bioscience Corp. shares were up 25%, to $6.14, in premarket trading after the company said it saw positive results from a ...
- Best, Strongest CBD Gummies: Top Brands of 2022on December 7, 2021 at 11:34 am
CBD gummies have remained one of the top-selling forms of hemp that a person could take for years, and for good reason.
- Workout-Related Benefits Of Cannabidiolon December 7, 2021 at 6:06 am
To view the original article, click here. There is some speculation about the consumption of cannabidiol for exercise. While there exists evidence to indicate that cannabidiol can help you with ...
- Fayette student’s project featured at ‘Science in Ag’ exhibiton December 6, 2021 at 1:56 pm
Fayette County student Aubrey Higginbotham was among the 8 students selected from across the state to display their agriculture science projects at last week’s Kentucky Farm Bureau (KFB) annual ...
- Global Cannabidiol Oil (CBD Oil) Market Size, Share Remuneration to Surge At 33.5% CAGR Through 2026on December 6, 2021 at 8:30 am
Dec 06, 2021 (Market Insight Reports) -- The report Cannabidiol Oil (CBD Oil) Market Size and Analysis maintains enhanced dynamics and is overshadowed by a top player across the globe. The ...
- U.S. Veterinarians Now Have Their Own Medical Cannabis Portalon December 6, 2021 at 8:00 am
With all the widespread and sometimes conflicting medical news on the use of cannabis for pets, having a trustworthy source of information is important. Thankfully, we now have one. A website that ...
- St. Louis-based cannabidiol retailer CBD Kratom expands New York presenceon December 6, 2021 at 4:24 am
CBD Kratom, a St. Louis-based retailer of cannabidiol, or CBD, products, is expanding its presence in New York City.
- The Global Cannabidiol CBD Market Is Predicted To Increase Nearly 28?GR from 2021 to 2031on November 30, 2021 at 6:50 am
The global CBD market study is a detailed market intelligence on pivotal revenue growth determinants, challenges, industry trends, and opportunities, which will eventually influence the growth ...
via Bing News